Citius pharmaceuticals, inc. (CTXR)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10
Cash Flows From Operating Activities:
Net Loss

-16,802

-16,009

-15,562

-14,759

-12,375

-13,165

-12,536

-12,732

-13,133

-11,455

-10,384

-9,931

-11,124

-9,250

-8,295

-6,614

-3,823

-3,299

-2,902

-2,606

-1,816

-1,561

-1,272

-674

-644

-564

-31

-21

-23

-20

-22

-19

-19

-19

-26

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation - general and administrative

720

765

715

729

649

660

779

807

949

1,035

986

1,024

1,036

852

732

620

505

498

486

851

687

578

470

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock for services and release agreements

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of operating lease right-of-use asset

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss (gain) on revaluation of derivative warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on revaluation of derivative warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

(Gain) loss on revaluation of derivative warrant liability

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock for release agreement

-

-

-

-

-

-

-

-

-

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation

0

0

0

0

0

1

1

2

2

2

2

2

2

2

1

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Other receivables

-

-

-818

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

7

9

-9

-28

-18

-64

-162

-284

-411

-526

-572

-707

-215

-114

40

0

0

0

-

-

-

-

-

-

-

0

-

-

0

0

-

-

-

-

-

-

-

-

Accounts payable

-401

-536

1,140

1,518

525

1,522

971

-1,065

-462

-424

-306

1,668

1,496

282

105

-269

-221

259

452

197

162

26

-83

-41

2

-6

11

0

0

0

-

-

-

-5

0

0

0

0

Accrued expenses

-26

8

64

42

33

34

70

-89

-1,263

-1,230

-397

69

852

713

351

-40

396

534

-52

26

4

-3

59

-1

1

1

-1

-0

0

0

0

0

0

0

-

-

-

-

Accrued compensation

11

94

201

269

224

178

135

-282

-286

192

159

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest - related parties

-16

-16

-16

-16

-15

-16

-15

-32

-62

-77

-87

-71

-40

-20

-7

-17

-15

-15

-7

26

56

86

103

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liability

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Due to related party

-

-

-

-

-

-

-27

0

0

-10

-

0

0

0

-

-

-

-

-

-

-

-

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

1

1

0

0

0

-

-

-

-

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

3

1

1

0

0

0

0

-

-

0

0

Net Cash Used In Operating Activities

-16,011

-15,393

-12,437

-12,035

-10,758

-11,035

-11,318

-12,242

-12,399

-9,097

-7,971

-6,308

-6,468

-6,518

-5,900

-4,838

-2,905

-2,347

-2,385

-1,782

-1,202

-917

-705

-610

-564

-542

-20

-18

-21

-18

-20

-19

-18

-19

-20

0

0

0

Net Cash Provided By (Used In) Investing Activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

Proceeds from (repayments of) bank overdrafts

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

-

-

-

-

-

-

-

-

Proceeds from notes payable – related parties

-

-

-

-

-

-

-

-

-

-

4,210

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

25

27

27

27

0

0

0

Net proceeds from common stock warrant exercises

6,027

7

23

23

23

16

1,125

0

0

1,125

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from notes payable - related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from promissory notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of related party debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

-

-

-

-

Repayments of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

-

-

-

-

Net proceeds from private placement

-

-

-

-

-

-

-

-

-

-

556

556

1,585

5,372

5,427

5,858

5,648

1,811

1,509

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net proceeds from public offering

-

-

-

-

-

-

-

13,362

13,362

11,599

6,116

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from non-related party debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

16

27

17

17

17

0

0

0

-

-

-

-

Net Cash Provided By Financing Activities

17,151

11,131

11,147

13,784

8,950

10,706

17,298

14,808

17,348

16,423

10,883

4,881

2,770

6,027

5,262

5,258

5,648

1,811

1,509

2,709

1,940

1,680

2,255

632

585

595

20

18

21

18

20

19

18

19

18

0

0

0

Net Change in Cash and Cash Equivalents

1,139

-4,261

-1,290

1,748

-1,808

-329

5,979

2,563

4,946

7,323

2,909

-1,427

-3,697

-234

-381

675

2,998

-535

-875

927

738

762

1,550

22

20

53

-0

-0

0

-0

-0

0

0

-0

-2

0

0

0

Supplemental Disclosures Of Cash Flow Information and Non-cash Activities:
Operating lease right-of-use asset and liability recorded upon adoption of ASC 842

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest paid

-

-

-

-

-

-

0

1

1

1

1

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Income taxes paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Fair value of private placement warrants recorded as derivative warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reclassification of derivative warrant liability to additional paid-in capital

-

-

-

-

-

-

-

-

-

-

1,229

1,877

1,792

1,242

1,093

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Par value of common stock issued upon cashless exercise of warrants

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fair value of private placement warrants recorded as derivative warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of promissory notes and accrued interest into common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of convertible promissory notes and accrued interest into common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,836

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-